AbbVie Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B | $8.45B | $39.92B | $7.29B |
| Accounts Receivable | $12.59B | $10.92B | $11.16B | $11.25B | $9.98B | $8.82B | $5.43B | $5.38B |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | $3.13B | $3.31B | $1.81B | $1.61B |
| Total Current Assets | $29.06B | $25.58B | $33.00B | $28.46B | $27.93B | $24.17B | $49.52B | $16.95B |
| Property, Plant & Equipment | $5.63B | $5.13B | $4.99B | $4.94B | $5.11B | $5.25B | $2.96B | $2.88B |
| Goodwill | $35.64B | $34.96B | $32.29B | $32.16B | $32.38B | $33.12B | $15.60B | $15.66B |
| Intangible Assets (Excl. Goodwill) | $52.64B | $60.07B | $55.61B | $67.44B | $75.95B | $82.88B | $18.65B | $21.23B |
| Total Assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.57B | $89.12B | $59.35B |
| Liabilities | ||||||||
| Accounts Payable | $3.59B | $2.95B | $3.69B | $2.93B | $2.88B | $2.28B | $1.45B | $1.55B |
| Total Current Liabilities | $43.29B | $38.75B | $37.84B | $29.54B | $35.19B | $28.66B | $15.59B | $17.24B |
| Long-Term Debt | $64.50B | $66.84B | $59.25B | $63.13B | $75.96B | $84.95B | $67.23B | — |
| Total Liabilities | $137.23B | $131.84B | $124.35B | $121.55B | $131.12B | $137.49B | $97.29B | $67.80B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-15.49B | $-7.90B | $-1.00B | $4.78B | $3.13B | $1.06B | $4.72B | $3.37B |
| Total Stockholders' Equity | $-3.27B | $3.33B | $10.36B | $17.25B | $15.41B | $13.08B | $-8.17B | $-8.45B |